Mill Creek Capital Advisors »

Context Therapeutics shares owned by Mill Creek Capital Advisors

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Mill Creek Capital Advisors from 13F filings

Historical chart of Mill Creek Capital Advisors investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Mill Creek Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Mill Creek Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $158k 105k 1.51
2023-06-30 $167k 105k 1.60
2023-03-31 $59k 105k 0.56
2022-12-31 $68k 105k 0.65

More positions owned by Mill Creek Capital Advisors

Vanguard Value Etf Etf (VTV)
Vanguard Growth Etf Etf (VUG)
Ishares Core Msci Total International Stock Etf Etf (IXUS)
Hartford Multifactor Developed Markets Ex Us Etf (RODM)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Vanguard Small Cap Value Etf Etf (VBR)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Franklin U.s. Low Volatility High Dividend Index Etf Etf (LVHD)
Ishares Msci Eafe Small-cap Etf Etf (SCZ)
Vanguard S&p 500 Etf Etf (VOO)
Ishares U.s. Treasury Bond Etf Etf (GOVT)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Small-cap Growth Etf Etf (VBK)
Vanguard Total Corporate Bond Etf Etf (VTC)
Johnson & Johnson Stock (JNJ)

View all positions for Mill Creek Capital Advisors

Top funds holding Context Therapeutics

Opaleye Management
Vanguard Group
HighTower Advisors
Clear Harbor Asset Management
Sheets Smith Wealth Management
Citadel Advisors
Aspire Wealth Management Corp
UBS Group
Advisor Group Holdings
Retirement Group
Wells Fargo & Company
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Context Therapeutics